Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$85.36
-1.1%
$94.46
$81.97
$139.06
$150.32B0.6511.57 million shs21.14 million shs
Citigroup Inc. stock logo
C
Citigroup
$125.73
+0.8%
$122.89
$74.30
$135.29
$212.65B1.1410.14 million shs17.33 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.97%-2.36%-6.74%-26.53%-35.36%
Citigroup Inc. stock logo
C
Citigroup
+0.78%+0.51%-1.31%+14.18%+67.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$85.36
-1.1%
$94.46
$81.97
$139.06
$150.32B0.6511.57 million shs21.14 million shs
Citigroup Inc. stock logo
C
Citigroup
$125.73
+0.8%
$122.89
$74.30
$135.29
$212.65B1.1410.14 million shs17.33 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.97%-2.36%-6.74%-26.53%-35.36%
Citigroup Inc. stock logo
C
Citigroup
+0.78%+0.51%-1.31%+14.18%+67.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.0939.52% Upside
Citigroup Inc. stock logo
C
Citigroup
2.80
Moderate Buy$137.629.45% Upside

Current Analyst Ratings Breakdown

Latest ABT and C Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$121.00 ➝ $113.00
5/8/2026
Citigroup Inc. stock logo
C
Citigroup
Reiterated RatingOutperform$145.00
5/8/2026
Citigroup Inc. stock logo
C
Citigroup
Boost Price TargetOutperform$140.00 ➝ $153.00
5/1/2026
Citigroup Inc. stock logo
C
Citigroup
Set Price Target$147.00
4/30/2026
Citigroup Inc. stock logo
C
Citigroup
Boost Price TargetOverweight$131.00 ➝ $135.50
4/29/2026
Citigroup Inc. stock logo
C
Citigroup
Boost Price TargetOverweight$160.00 ➝ $162.00
4/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingBuy$131.00
4/24/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C)Hold (C-)
4/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeOutperformNeutral$92.00
4/21/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$140.00 ➝ $125.00
4/21/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetMarket Perform$119.00 ➝ $106.00
(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.35$6.91 per share12.35$30.26 per share2.82
Citigroup Inc. stock logo
C
Citigroup
$168.30B1.27$11.97 per share10.50$113.17 per share1.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5723.9114.091.4413.90%17.62%10.01%7/16/2026 (Estimated)
Citigroup Inc. stock logo
C
Citigroup
$14.31B$8.0715.5810.120.569.35%9.19%0.67%7/14/2026 (Estimated)

Latest ABT and C Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
4/14/2026Q1 2026
Citigroup Inc. stock logo
C
Citigroup
$2.63$3.06+$0.43$3.06$22.96 billion$24.63 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.95%+10.39%70.59%54 Years
Citigroup Inc. stock logo
C
Citigroup
$2.401.91%+2.61%29.74%2 Years

Latest ABT and C Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/2/2026
Citigroup Inc. stock logo
C
Citigroup
quarterly$0.601.91%5/4/20265/4/20265/22/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Citigroup Inc. stock logo
C
Citigroup
1.59
0.99
0.99

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Citigroup Inc. stock logo
C
Citigroup
71.72%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Citigroup Inc. stock logo
C
Citigroup
0.11%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Citigroup Inc. stock logo
C
Citigroup
226,0001.71 billion1.70 billionOptionable

Recent News About These Companies

EU's six biggest economies agree on capital markets supervision
Danish pension fund excludes SpaceX citing governance and valuation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$85.36 -0.94 (-1.09%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$85.55 +0.20 (+0.23%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Citigroup stock logo

Citigroup NYSE:C

$125.73 +1.05 (+0.84%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$125.45 -0.28 (-0.22%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Citigroup Inc., a diversified financial service holding company, provides various financial product and services to consumers, corporations, governments, and institutions worldwide. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes Treasury and Trade Solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and Securities Services, such as cross-border support for clients, local market expertise, post-trade technologies, data solutions, and various securities services solutions. The Markets segment offers sales and trading services for equities, foreign exchange, rates, spread products, and commodities to corporate, institutional, and public sector clients; and market-making services, including asset classes, risk management solutions, financing, prime brokerage, research, securities clearing, and settlement. The banking segment includes investment banking; advisory services related to mergers and acquisitions, divestitures, restructurings, and corporate defense activities; and corporate lending, which includes corporate and commercial banking. The U.S. Personal Banking segment provides co-branded cards and retail banking services. The Wealth segment provides financial services to high-net-worth clients through banking, lending, mortgages, investment, custody, and trust product offerings; and to professional industries, including law firms, consulting groups, accounting, and asset management. The company was founded in 1812 and is headquartered in New York, New York.